BTN2A3P

Across TCGA pan-cancer cohorts, BTN2A3P RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated BTN2A3P data layer compared with 2 for mutation status.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher BTN2A3P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated BTN2A3P expression acts as an unfavorable survival marker, although some lineages such as READ and UCEC show a favorable association.

ACC, READ, and LGG are the cancer types where BTN2A3P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Median	All	0.428	0.730	<.001	96	view →
READ	OS	Tertile	II,III,IV	0.961	0.381	<.001	63	view →
LGG	DFS	Median	All	0.606	0.861	<.001	54	view →
UCEC	OS	Quartile	IV	0.799	0.387	.003	34	view →
HNSC	OS	Median	All	0.304	0.485	.003	28	view →
ESCA	OS	Median	IV	0.222	0.698	.006	27	view →
UVM	DFS	Quartile	III,IV	0.234	0.832	.004	24	view →
LUAD	OS	Median	II,III,IV	0.773	0.648	.003	22	view →
LUSC	DFS	Quartile	III,IV	0.434	0.951	.008	20	view →
BRCA	DFS	Quartile	III,IV	0.671	0.351	.006	19	view →
SKCM	DFS	Median	IV	0.187	0.763	.006	18	view →
COAD	DFS	Quartile	II,III,IV	0.662	0.841	.007	11	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 25 lineages.

BTN2A3P–ACC (DFS)

Open the ACC breakdown →